Quantification of Tumor Volume Changes During Radiotherapy for Non-Small-Cell Lung Cancer

International Journal of Radiation Oncology Biology Physics

Volumn 74, Issue 2, 2009, Pages 341-348

  Fox, Jana ^a   Ford, Eric ^a   Redmond, Kristin ^a   Zhou, Jessica ^a   Wong, John ^a   Song, Danny Y ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adaptive radiotherapy; Non small cell lung cancer; Volume changes

Indexed keywords

ADAPTIVE APPROACHES; ADAPTIVE RADIOTHERAPY; CHEMORADIOTHERAPY; COMPUTED TOMOGRAPHY SCANS; CONCURRENT CHEMOTHERAPIES; CONVENTIONAL FRACTIONATIONS; CT SCANS; DOSE ESCALATIONS; GROSS TUMOR VOLUMES; IMAGE SETS; LUNG CANCERS; NON-SMALL-CELL LUNG CANCER; NORMAL STRUCTURES; NORMAL-TISSUE TOXICITIES; REDUCING TREATMENTS; RESPIRATORY EFFECTS; SIMULATION DATUM; STATISTICAL SIGNIFICANCES; T-TESTS; TARGET TISSUES; TUMOR VOLUMES; VOLUME CHANGES; VOLUME REDUCTIONS;

CHEMOTHERAPY; COMPUTERIZED TOMOGRAPHY; MEDICAL IMAGING; RADIOTHERAPY; TUMORS;

BIOLOGICAL ORGANS;

CARBOPLATIN; CETUXIMAB; CISPLATIN; DOCETAXEL; ETOPOSIDE; PACLITAXEL;

ARTICLE; BREATHING; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DOSIMETRY; HUMAN; LUNG NON SMALL CELL CANCER; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIATION DOSE FRACTIONATION; SIMULATION; STUDENT T TEST; TARGET ORGAN; TUMOR VOLUME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; HUMANS; LUNG NEOPLASMS; RADIOTHERAPY DOSAGE; TOMOGRAPHY, X-RAY COMPUTED; TUMOR BURDEN;

EID: 67349137431     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.07.063     Document Type: Article

References (24)

1. Furuse K., Fukuoka M., Kawahara M., et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. J Clin Oncol 17 (1999) 2692-2699
2. Curran W.J., Scott C., and Langer C. Long-term benefit is observed in a phase III comparison of sequential vs concurrent chemo-radiation for patients with unresected stage III non small cell lung cancer: RTOG 9410. [Abstract]. Proc Am Soc Clin Oncol 22 (2003) 621
3. Gandara D.R., Chansky K., Albain K.S., et al. Consolidation docetaxel after concurrent chemoradiotherapy in stage IIIB non-small-cell lung cancer: Phase II Southwest Oncology Group study S9504. J Clin Oncol 21 (2003) 2004-2010
4. Albain K.S., Swann R., and Rusch V.R. Phase III study of concurrent chemotherapy and radiotherapy (CT/RT) vs CT/RT followed by surgical resection for stage IIIA (pN2) non-small cell lung cancer (NSCLC): Outcomes update of North American Intergroup 0139 (RTOG 9309). [Abstract]. J Clin Oncol 23 16S (2005) 7014
5. Belderbos J.S., Heemsbergen W.D., De Jaeger K., et al. Final results of a phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 66 (2006) 126-134
6. Bradley J., Graham M.V., Winter K., et al. Toxicity and outcome results of RTOG 9311: A phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma. Int J Radiat Oncol Biol Phys 61 (2005) 318-328
7. Hayman J.A., Martel M.K., Ten Haken R.K., et al. Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: Update of a phase I trial. J Clin Oncol 19 (2001) 127-136
8. Rosenzweig K.E., Fox J.L., Yorke E., et al. Results of a phase I dose-escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable nonsmall cell lung carcinoma. Cancer 103 (2005) 2118-2127
9. Ford E.C., Mageras G.S., Yorke E., et al. Respiration-correlated spiral CT: A method of measuring respiratory-induced anatomic motion for radiation treatment planning. Med Phys 30 (2003) 88-97
10. Vedam S.S., Keall P.J., Kini V.R., et al. Acquiring a four-dimensional computed tomography dataset using an external respiratory signal. Phys Med Biol 48 (2003) 45-62
11. Wong J.W., Sharpe M.B., Jaffray D.A., et al. The use of active breathing control (ABC) to reduce margin for breathing motion. Int J Radiat Oncol Biol Phys 44 (1999) 911-919
12. Weiss E., Wijesooriya K., Dill S.V., et al. Tumor and normal tissue motion in the thorax during respiration: Analysis of volumetric and positional variations using 4D CT. Int J Radiat Oncol Biol Phys 67 (2007) 296-307
13. Kupelian P.A., Ramsey C., Meeks S.L., et al. Serial megavoltage CT imaging during external beam radiotherapy for non-small-cell lung cancer: Observations on tumor regression during treatment. Int J Radiat Oncol Biol Phys 63 (2005) 1024-1028
14. Siker M.L., Tome W.A., and Mehta M.P. Tumor volume changes on serial imaging with MV CT for non-small-cell lung cancer during intensity-modulated radiotherapy: How reliable, consistent, and meaningful is the effect?. Int J Radiat Oncol Biol Phys 66 (2006) 135-141
15. Britton K.R., Starkschall G., Tucker S.L., et al. Assessment of gross tumor volume regression and motion changes during radiotherapy for non-small-cell lung cancer as measured by four-dimensional computed tomography. Int J Radiat Oncol Biol Phys 68 (2007) 1036-1046
16. Fowler J.A., Tome W.A., Fenwick J.D., and Mehta M.P. A challenge to traditional radiation oncology. Int J Radiat Oncol Biol Phys 60 (2004) 1241-1256
17. Underberg R.W., Lagerwaard F.J., van Tinteren H., et al. Time trends in target volumes for stage I non-small-cell lung cancer after stereotactic radiotherapy. Int J Radiat Oncol Biol Phys 64 (2006) 1221-1228
18. Bosmans G., van Baardwijk A., Dekker A., et al. Intra-patient variability of tumor volume and tumor motion during conventionally fractionated radiotherapy for locally advanced non-small-cell lung cancer: A prospective clinical study. Int J Radiat Oncol Biol Phys 66 (2006) 748-753
19. Giraud P., Antoine M., Larrouy A., et al. Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning. Int J Radiat Oncol Biol Phys 48 (2000) 1015-1024
20. Grills I.S., Fitch D.L., Goldstein N.S., et al. Clinicopathologic analysis of microscopic extension in lung adenocarcinoma: Defining clinical target volume for radiotherapy. Int J Radiat Oncol Biol Phys 69 (2007) 334-341
21. Macmanus M., D'Costa I., Everitt S., et al. Comparison of CT and positron emission tomography/CT coregistered images in planning radical radiotherapy in patients with non-small-cell lung cancer. Australas Radiol 51 (2007) 386-393
22. Greco C., Rosenzweig K., Cascini G.L., et al. Current status of PET/CT for tumour volume definition in radiotherapy treatment planning for non-small cell lung cancer (NSCLC). Lung Cancer 57 (2007) 125-134
23. Miyamoto M., Baba M., Sugane T., et al. Carbon ion radiotherapy for stage I non-small cell lung cancer using a regimen of four fractions during 1 week. J Thorac Oncol 2 (2007) 916-926
24. Schulz-Ertner D., and Tsujii H. Particle radiation therapy using proton and heavier ion beams. J Clin Oncol 25 (2007) 953-964